DAVID GRANOVSKY

Archive for the ‘VICTORIES & SUCCESS STORIES’ Category

CHILD RECEIVES NEW STEM CELL TRACHEA

In ALL ARTICLES, STEM CELLS IN THE NEWS, VICTORIES & SUCCESS STORIES on April 30, 2013 at 2:44 pm
ht_ciaran_finn_lynch_trachea_transplant_ll_120725_wg

Two years ago, 11 year old Ciaran Finn-Lynch, became the world’s first child to receive new trachea.  Scientists/doctors used the child’s own stem cells to rebuild the airway in his body.  This is the really cool stuff because the public can wrap their heads around it and see a trachea in a dish, a nose growing on an arm, etc.  The next step in evolution of the public consciousness is to get them to understand…we can regrow and heal the organs which are already present in their own bodies, already damaged and in need of fixing…with stem cells from their own body.  I think this will be difficult as the home owner with the means will almost always go to the outside plumber or the super store and get a new piece of equipment to replace the old rather than pick up a wrench and fix what they have already.  Another byproduct of the disposable society we live in.  Homes, cars, washing machines and now organs are believed to have a limited life span.  When it breaks, just buy a new one.  - DG

Here’s the article from ScienceDaily:

Surgeons Transplant New Trachea Into Child Using His Own Stem Cells to Rebuild Airway

http://www.sciencedaily.com/releases/2010/03/100325114400.htm

Which was written based on materials from the University College of London release (what, you thought this was in the US?):

UCL surgeons perform revolutionary transplant operation

http://www.ucl.ac.uk/news/news-articles/1003/10031903

trachea

Here’s the 2 year follow-up:

Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study.

http://www.ncbi.nlm.nih.gov/pubmed/22841419

And the human interest story coverage of the same:

Stunning Recovery for First Child to Get Stem Cell Trachea

http://abcnews.go.com/Health/stunning-recovery-child-stem-cell-trachea/story?id=16858771

STEM CELLS COME TO THE USA!!!

In STEM CELLS IN THE NEWS, VICTORIES & SUCCESS STORIES on April 23, 2013 at 9:00 am

usa-flag-grunge

 Stem Cells Come to the USA!

A real possibility is that all off shore facilities will go under shortly as people realize stem cells are coming to the USA.   Not only “the smart patient” but also “the smart investor” will return home.   Please forward to relevant parties and contact me if you want to know what the next step is to US based stem cell facilities and treatments.

DrugTrialsKUMedLeukemiaSociety-13-0-315-153 304

Brownback signs into law bill establishing adult stem cell research and treatment at KU Medical Center

Topeka — In a mix of science and anti-abortion politics, Gov. Sam Brownback on Monday signed into law a bill that establishes the nation’s first adult stem cell research and treatment center at the Kansas University Medical Center.

“I am honored to sign this bill of hope and promise and current treatments,” Brownback said.

Brownback described adult stem cell and umbilical cord blood research as an “exploding” area of new discoveries to treat people with a wide range of diseases. “KU will be the leader, Kansas will be the leader, which is fabulous in this burgeoning field,” he said.

But the bill carried political overtones.

It was sponsored by vehement abortion opponents and pushed by the Family Research Council, a conservative Christian lobbying group.

In addition, KU never asked for the legislation establishing what will be known as the Midwest Stem Cell Center, and the Legislature has yet to produce the estimated $1.1 million needed for the center’s startup.

Dr. Buddhadeb Dawn, director of the Division of Cardiovascular Diseases at KU Medical Center, on Monday speaks during Gov. Sam Brownback’s bill-signing ceremony on legislation establishing the Midwest Stem Adult Stem Cell Center.  The center will be charged with working on adult stem cell, cord blood and related stem cell research, providing therapies to patients and serving as a clearinghouse for physicians on cutting-edge treatments.  The center is prohibited from using embryonic stem cells or cells taken from aborted fetal tissue.  Abortion opponents oppose human embryonic stem cell research because it involves the destruction of the embryo.

Dr. Buddhadeb Dawn, director of the Division of Cardiovascular Diseases at KU Medical Center, was the only KU representative on hand at the bill-signing ceremony. He said the number of clinical trials of bone marrow stem cells for treatment of heart disease had been increasing tremendously over the past several years.

“It would be great to bring such therapies to Kansas, and the formation of such a center which would engage in adult stem cell therapy in patients would give Kansans the chance to be enrolled in such therapy and perhaps give treatment that would change their life,” he said.

David Prentice, senior fellow for life sciences at the Family Research Council, said the center “puts Kansas in a leadership position.”

State Sen. Mary Pilcher Cook, R-Shawnee, who carried the bill in the Legislature said she would push for funding the center when the Legislature returns May 8 for the wrap-up session.

“That’s all under discussion right now,” she said.

At the bill-signing ceremony, several people who have survived diseases spoke about their treatments and how they believed the new center would expand the availability of treatments for others.

Mary Rusco, of Wichita, said she received stem cells from an umbilical cord.

“I have been cancer free for four years now, and as far as I’m concerned I’m cured. I really appreciate the fact that Kansas is doing this so that other people can have access to this opportunity,” she said.

Terry Killman, of Independence, received a bone marrow transplant from his brother.

“This bill will make it that much better for more people to have the opportunity that I’ve had to live,” he said.

Summary of Senate Bill 199 ( .PDF )

KIDNEY BREAKTHROUGH: COMPLETE LAB GROWN ORGAN WORKS IN RATS

In ALL ARTICLES, STEM CELLS IN THE NEWS, VICTORIES & SUCCESS STORIES on April 19, 2013 at 4:00 pm
A brand new rat kidney being built on the scaffold of an old one <i>(Image: Ott Lab, Center for Regenerative Medicine, Massachusetts General Hospital)</i>

A brand new rat kidney being built on the scaffold of an old one

(Image: Ott Lab, Center for Regenerative Medicine, Massachusetts General Hospital)

Kidney breakthrough: complete lab-grown organ works in rats

 

  • 18:00 14 April 2013 by Andy Coghlan

 

For the first time, complete lab-grown kidneys have been successfully transplanted into rats, filtering and discharging urine as a normal kidney would.

 

The breakthrough paves the way for human-scale versions, which could potentially provide an inexhaustible supply of organs, eliminating the need for recipients to wait for a matching donor kidney Movie Camera.

 

Similar techniques have already been applied successfully in people with simpler tissue, such as windpipes. But the kidney is by far the most complex organ successfully recreated.

 

“If this technology can be scaled to human-size grafts, patients suffering from renal failure, who are currently waiting for donor kidneys, could theoretically receive an organ grown on demand,” says Harald Ott, head of the team that developed the rat kidneys at the Massachusetts General Hospital in Boston.

 

“In an ideal world, such grafts could be produced from patient-derived cells, enabling us to overcome both donor organ shortages and the need for long-term immunosuppression drugs,” says Ott. Currently in the US alone, 18,000 transplants are carried out each year, but 100,000 Americans remain on waiting lists.

 

Strip and coat

 

To make the rat kidneys, Ott and his colleagues took kidneys from healthy “donor” rats and used a chemical solution to wash away the native cells, leaving behind the organ’s scaffold. Because this is made of collagen, a biologically inert material, there is no issue of the recipient’s body rejecting it.

 

Next, the team set about regrowing the “flesh” of the organ by coating the inner surfaces of the scaffold with new cells. In the case of humans, these would likely come from the recipient, so all the flesh would be their own.

 

The kidney was too complex to use the approach applied to the windpipe – in which its scaffold was coated by simply immersing it in a bath of the recipient’s cells.

 

Instead, the team placed the kidney scaffolds in glass chambers containing oxygen and nutrients, and attached tubes to the protruding ends of the renal artery, vein and ureter – through which urine normally exits the kidney. They recoated the insides of the blood vessels by flowing human stem cells through the tubes attached to the artery and vein. Through the ureter, they fed kidney cells from newborn rats, re-coating the labyrinthine tubules and ducts that make up the kidney’s urine filtration system.

 

It took many attempts to establish the precise pressures at which to feed the cells into the organ, as if it was growing in an embryonic rat. Remarkably, given the complexity of the kidney, the cells differentiated into exactly those required in the different compartments of the organ. “We found the correct cell types homed in to specific regions in the organ matrix,” says Ott.

 

The kidneys, which took about a fortnight to fully recoat, worked both in the lab and when transplanted into rats. They filtered out and discharged urine, although they did not sieve it as well as a natural kidney would. Ott is confident that the function can be improved by refining the technique.

 

Humans and pigs

 

The team is now attempting the same procedure using human kidneys, and also pig kidneys, which could be used to make scaffolds if there were a scarcity of human donors. The team has already successfully repopulated pig kidneys with human cells, but Ott says further studies are vital to guarantee that the pig components of the organ do not cause rejection when transplanted into humans.

 

The fact that heart valves and other “inert” tissues from pigs are already successfully used in humans without rejection suggests that this will not be a big problem.

 

Other researchers working in the field hailed the team’s success at recreating such a complex organ. “The researchers have taken a technique that most in the field thought would be impossible for complex organs such as the kidney, and have painstakingly developed a method to make it work,” says Jamie Davies at the University of Edinburgh, UK, who was part of a team that last year made some headway in their attempts to grow kidneys from scratch in the lab. “By showing that recellularisation is feasible even for complicated organs, their work will stimulate similar approaches to the engineering of other body systems.”

 

Journal reference: Nature Medicine, DOI: 10.1038/nm.3154

STEM CELL THERAPY INCREASES SUCCESS RATE OF LIVER TRANSPLANTS

In ALL ARTICLES, STEM CELLS IN THE NEWS, VICTORIES & SUCCESS STORIES on March 20, 2013 at 9:00 am

Liver-transplant-006

Stem cell therapy is new hope for liver transplant patients

Stem cell therapy has been found useful in over 60 per cent of the patients due for liver transplant, as per a paper submitted by doctors at Sir Ganga Ram Hospital in Delhi recently. Not only is the treatment less cumbersome and risky, its cost is also comparatively very reasonable.

According to the paper’s principal author and chairman of the Department of Gastroenterology and Liver Diseases at the Hospital, Dr. Anil Arora, a large number of patients requiring liver transplantation cannot afford it for two reasons – cost and donor availability.

In view of the logistical problems faced by such patients, Dr. Arora said: “We started looking at the feasibility of alternative methods like using reserve cells in the body for such treatment, as it costs even less.  Some of these cells can be mobilized from the bone marrow as it has the capacity to regenerate the cells. So we stimulate the bone marrow by an injection.”

“This injection is given for five days and it mobilizes the bone marrow and some of the cells. They then come into the blood circulation. In the study we tried to filter these cells from the blood marrow using a specialized filtering machine and the concentrate of these cells. About 5 ml to 10 ml of the blood containing these concentrated group of cells were then injected into the hepatic artery, which supplies blood to the liver,” explained Dr. Arora. He said this process was carried out by a number of different mechanisms and it proved quite successful. “We started about two years ago and finished last year. Then these patients were followed up for another one year and we were happy to see a significant proportion of the patients having substantial improvement in the liver functions as assessed by a score called ‘Child score’.”

Dr. Arora said, “All patients tolerated the treatment well without any side effects. Of the 10 patients, six to seven benefited. So we believe that more frequent administration of the stem cells in large number might have a more beneficial impact.”

While the study by the Sir Ganga Ram Hospital team was published this year and was approved by the Department of Biotechnology and Ministry of Science and Technology, Government of India, Dr. Arora said there is also other published data now which calls for “stimulating the bone marrow and letting the cells automatically go into the liver”. By this, he said, you avoid filtering and putting the blood with the stem cells into the liver. “This is also equally beneficial.”

Dr. Arora said stem cell therapy “might act as a bridge for liver transplant” and can provide some time to the patients to arrange for treatment. But just like a damaged car tire, he said, a damaged liver after minor repairs has to be replaced. “However, if a person stops taking liquor or if the therapy goes on well, then a patient can lead a healthy life for many more years.”

http://www.thehindu.com

Stem Cells from Human Adipose Tissue Used to Chase Migrating Cancer Cells

In ALL ARTICLES, STEM CELLS IN THE NEWS, VICTORIES & SUCCESS STORIES on March 15, 2013 at 11:21 am
Stemness of primary AMSC lines demonstrated with differentiation along three mesenchymal lineages, Adipocyte (a, d [48], g), Osteocyte (b [48], e, h), and Chondrocyte (c [48], f, i), documented via lineage specific staining with Oil Red O, Alizarin Red, and Collagen II, respectively. (Credit: Pendleton et al. Mesenchymal Stem Cells Derived from Adipose Tissue vs Bone Marrow: In Vitro Comparison of Their Tropism towards Gliomas. PLoS ONE, 2013; 8 (3): e58198 DOI: 10.1371/journal.pone.0058198)
Using Fat to Fight Brain Cancer: Stem Cells from Human Adipose Tissue Used to Chase Migrating Cancer Cells

Mar. 12, 2013 — In laboratory studies, Johns Hopkins researchers say they have found that stem cells from a patient’s own fat may have the potential to deliver new treatments directly into the brain after the surgical removal of a glioblastoma, the most common and aggressive form of brain tumor.


The investigators say so-called mesenchymal stem cells (MSCs) have an unexplained ability to seek out damaged cells, such as those involved in cancer, and may provide clinicians a new tool for accessing difficult-to-reach parts of the brain where cancer cells can hide and proliferate anew. The researchers say harvesting MSCs from fat is less invasive and less expensive than getting them from bone marrow, a more commonly studied method.

A DOG’S LIFE SAVED THROUGH STEM CELL TREATMENT

In STEM CELLS IN THE NEWS, VICTORIES & SUCCESS STORIES on March 6, 2013 at 9:00 am

This is Thelma. She is an adorable, friendly, 7 year old Boxer. Thelma was to be put down because she was suffering from Intervertebral Disc Disease (IVDD) in her neck. It was ultimately decided however to try stem cell therapy, performed by Pet Central Animal Hospital in Minneapolis, MN. This is a video of her BEFORE MediVet America’s stem cell procedure…..
AFTER: This is the after video of Thelma’s AMAZING progress after just 9 weeks from being treated with stem cell therapy!

ROBIN ROBERTS HEALS WITH ADULT STEM CELLS, BONE MARROW TRANSPLANT

In ALL ARTICLES, STEM CELLS IN THE NEWS, VICTORIES & SUCCESS STORIES on February 28, 2013 at 1:34 pm

RobinRoberts73

Robin Roberts Returns to GMA. Use of adult stem cells to treat her blood disorder overlooked

Once again a jaunt on the old Gold’s Gym treadmill paid results. Although I had forgotten all about it, Good Morning America co-anchor Robin Roberts was making her triumphant return to ABC’s #1 rated morning show after being on medical leave following a bone marrow transplant to treat a rare blood disorder myelodysplastic syndrome (MDS).

It was great television: a close up of Roberts who told her audience, “”I’ve been waiting 174 days to say this: ‘Good morning, America.’”

During the course of the program (obviously much of which was devoted to Roberts), she reflected on faith, family and physicians.

“There’s so many people that I want to thank throughout the morning, my doctors and nurses and family and colleagues and people who have sat in this chair and those who have blazed the trail before me,” Roberts said. “As my mother said, ‘We all have something.’ Everyone’s story has purpose and meaning and value and I share this morning, this day of celebration with everyone.”

Besides a wonderful story of triumphing over cancer, there is a special association for pro-lifers. Indeed, if the full ramifications of the stories about Roberts were more widely known, it would be a real eye-opener.

MDS damages the bone marrow, making it no longer able to make the healthy cells and platelets we all need to live. Her older sister, Sally-Ann, was Robin’s bone marrow donor. In the procedure, a patient’s damaged bone marrow is eradicated and then replaced with healthy, donated marrow.

Although the words were not used, in fact, the transplant is another example of the successful, even routine use of adult stem cells.

As we reported at the time of the transplant, hematologist-oncologist Colleen Delaney, director of the program in cord blood transplant and research at Fred Hutchinson Cancer Research Center in Seattle, said, “We always call it a bone marrow transplant, but really it is a transplant with blood stem cells.”

Another terrific source is umbilical cord blood.

Obviously there is a better chance of success the closer the match between donor and recipient cells. Ms. Roberts was especially fortunate because her sister was an excellent match. (Finding a family match happens only about 30% of the time, according to a USA Today’s story.)

“The other 70% (more than 10,000 patients each year) have to turn to an unrelated adult donor or donated umbilical cord blood,” wrote Michelle Healy. “Often treated as waste and discarded, umbilical cords and placentas are rich with blood-forming cells, and more recent studies show the outcomes of cord blood transplants ‘are just as good as conventional donor outcomes,’ Delaney said.”

And “Because cord blood transplants don’t require the close genetic matching needed for more conventional bone marrow transplants, they hold special promise for the thousands of patients each year who can’t find a well-matched, unrelated donor, a particular challenge for people of mixed ethnicity and minority backgrounds, says Delaney.”

NRL News Today asked Dr. David Prentice, an expert on the issue of stem cells, to comment. “It is so heartening to see her return, and it further validates the life-saving abilities of adult stem cells,” he said. “I hope she’ll become a champion to speak out and educate people about the real promise of stem cells–adult stem cells.  Many more lives could be saved if only more people were aware of the successes, shown by her example and thousands of others.”

Prentice noted that “No doubt, it’s a harrowing experience for MDS patients leading up to the transplant, with chemotherapy to destroy the cancer in the body.” However, “the adult stem cell transplant is a short and simple procedure—an IV injection into a vein, and the millions of adult stem cells begin looking for a new home. In this case, they will look to make themselves at home as new bone marrow, and begin producing new red blood cells to carry oxygen, white blood cells for immunity, and platelets for clotting.”

His conclusion speaks volume:

“The more we focus on adult stem cells, the sooner we’ll find gentler and more efficient methods for transplants like this one, for other types of cancers, for anemias, as well as spinal cord injury, heart damage, and dozens of other conditions.  Adult stem cells are truly the patient’s best friend.”

HUMAN NOSE GROWN THROUGH STEM CELLS ON PATIENTS ARM

In ALL ARTICLES, SCIENCE & STEM CELLS, VICTORIES & SUCCESS STORIES on February 27, 2013 at 9:00 am

nose-growing-on-arm-omg

Havana (PL). – A British businessman suffering from a cancer that cost him his nose expects to recover the affected organ by a novel technique of reconstruction from its own tissue.  The procedure is being developed by researchers from the University College London (UCL), and it is about making the nasal appendage grow into the patient’s arm in order to transplant it later to the face, hoping also this part can recover the sense of smell.

According to experts, the new nose began to form in a biodegradable mold -based on the original one- with a synthetic material where millions of stem cells were injected.  At the same time they worked the skin of one of the arms, which was extended gradually with a small inflated ball housed beneath the surface. Two months later the ball was replaced by the nose in training, where the appendix is now acquiring networks of nerves and small blood vessels, as well as a skin cover.

After three months, the nose will be grafted into the man’s face, in an operation so precise that it should leave no scars. Whereas his arm will return to normal, said the attending physician team.  Scientists are convinced of the success of the procedure, and they explained that the nasal structure will be even slightly curved to the left, very similar to that lost as a result of their illness.

Some time ago a team of Spanish surgeons rebuilt the face of two children who suffered a serious facial hemiatrophy with adult stem cells extracted from adipose tissue of patients.  This technique, which not only generates volume but also regenerates tissues, is about practicing millimeter punctures in the children abdomen, in order to suck, through liposuction cannulas, the fat that is deposited there.  The material is processed in an aseptic manner, and from the fat are extracted the purest stomach stem cells with the higher regenerative properties, which are mixed with the fatty tissue for immediate re implantation into the patient, in an operation not very complex, they said.

The benefits of this therapy can be transferred to any other soft tissue atrophy, and the results are evident in a few months, because stem cells are regenerated and optimize the quality of the implant after a while, they said.

In fact, a similar technique for breast reconstruction and for improving cardiac function in myocardial infarction has been used.  Besides it has been successful in repairing tissues such as the trachea, esophagus and skeletal muscle in animal and human models, while advancing in the regeneration of organs such as liver, heart and lungs.

CELL THERAPY AND REGENERATIVE MEDICINE

Throughout life, cells forming tissues wear out and are degenerated. Advances in medicine based on replacement techniques of damaged tissue have been a revolution not without problems, including the limitation on the number of donor organs, and immunological complications (graft rejection), partly resolved with medication.  It is known that tissue forming part of the body have naturally the intrinsic capacity to self-renew, a process which occurs thanks to the remaining cells with capacity of differentiation.  This has opened a new era in the so-called regenerative medicine using stem cells, which is nothing but exploiting the natural mechanisms of cell renewal to repair damaged tissues, a new concept that opens possible therapeutic paths for certain diseases considered incurable at present.

The old dream of scientists to create organs on demand seems, judging by the progress made, ever closer.

* Journalist of the Science and Technology Editorial Department of Prensa Latina News Agency.

BETTER QUALITY OF LIFE FOR ELDERLY STEM CELL PATIENTS

In ALL ARTICLES, STEM CELLS IN THE NEWS, VICTORIES & SUCCESS STORIES on February 21, 2013 at 9:35 pm
Stem Cell Transplantation Safe For Elderly Patients

learnjiujitsu11513

ARLINGTON HEIGHTS, Ill., Feb. 19, 2013 /PRNewswire-USNewswire/ – Researchers have shown that stem cell transplantation for elderly patients with blood cancers, such as leukemia, lymphoma or myelodysplastic syndrome (MDS), is safe and effective, according to research presented last week in Salt Lake City at the 2013 BMT Tandem Meetings, the combined annual meetings of the American Society for Blood and Marrow Transplantation (ASBMT) and the Center for International Blood & Marrow Transplant Research.

Prior to this study, little was known about the safety of stem cell transplants in patients over the age of 70, who may have previously been excluded as candidates for stem cell transplantation because of their age.

This news about stem cell transplants comes as Robin Roberts returns as a host of Good Morning America tomorrow, five months after her successful transplant for MDS, a pre-leukemia blood disease that affects healthy blood cell formation in the bone marrow.  Although Roberts is younger, more than 80% of newly diagnosed MDS cases occur in people over the age of 60.

According to the research presented at the BMT Tandem Meetings, 56 patients age 70 or older, most of whom received transplants for acute leukemia or MDS, were identified for the study.  After being treated with low doses of chemotherapy and radiation, the majority of the patients received a peripheral blood stem cell transplant from a matched unrelated donor, while the remainder of the group received a transplant from a matched related donor.

surfing granny

Among the findings in 46 patients who experienced nadir (when blood cell counts are at their lowest):

  • the median time for blood cell counts to return to normal was 13 days;
  • one year after transplant, the incidence of chronic graft-versus-host disease, a common transplant complication, was 37%;
  • the incidence of survival without disease progression one year after transplant was 42%;
  • the incidence of overall survival one year after transplant was 55%;
  • the cumulative incidence of relapse was 34%;
  • at day 100, a critical time for stem cell transplants, the incidence of non-relapse mortality was only 3.6%; and
  • the incidence of non-relapse mortality one year after transplant was only 5.5%.

“Particularly newsworthy in this year in which we celebrated the performance of the 1 millionth transplant worldwide were the presentations related to increasing the use of stem cell transplantation in older patients with acute leukemia and MDS,” said Sergio Giralt , MD, president-elect of the ASBMT and the hematologist/oncologist who performed Roberts’ stem cell transplant.  “This abstract presented at the BMT Tandem Meetings demonstrates the feasibility and relatively good outcomes of patients over the age of 70 undergoing stem cell transplantation for a variety of blood cancers.”

The BMT Tandem Meetings abstract book is published as a supplement to the February issue of Biology of Blood and Marrow Transplantation, the peer-reviewed, scientific journal of the ASBMT.  The study, led by Andrew Brunner , MD, was conducted by researchers from Massachusetts General Hospital and Dana Farber Cancer Institute, both located in Boston.

The American Society for Blood and Marrow Transplantation is an international professional membership association of physicians, investigators and other healthcare professionals promoting blood and marrow transplantation and cellular therapy research, education, scholarly publication and clinical standards.

Contact:
Thomas L. Joseph , MPS, CAE
Executive Director, ASBMT
(847) 427-0224

SOURCE American Society for Blood and Marrow Transplantation

http://www.prnewswire.com/news-releases/stem-cell-transplantation-safe-for-elderly-patients-191850851.html

Elderly MDS Patients May Achieve Long-Term Survival From Stem Cell Transplantation (ASCO 2012)

Elderly patients with myelodysplastic syndromes or acute myeloid leukemia may experience long-term survival after undergoing stem cell transplantation, according to a recent study conducted at the MD Anderson Cancer Center in Houston.

ADULT STEM CELLS USED TO SUCCESSFULLY REBUILD A HUMAN TRACHEA

In ALL ARTICLES, SCIENCE & STEM CELLS, STEM CELLS IN THE NEWS, VICTORIES & SUCCESS STORIES on February 20, 2013 at 9:03 am

trachea

Tissue-Engineered Trachea Transplant Is Adult Stem Cell Breakthrough

The first tissue-engineered trachea (windpipe), utilizing the patient’s own stem cells, has been successfully transplanted into a young woman with a failing airway. The bio-engineered trachea immediately provided the patient with a normally functioning airway, thereby saving her life.  These remarkable results provide crucial new evidence that adult stem cells, combined with biologically compatible materials, can offer genuine solutions to other serious illnesses.  In particular, the successful outcome shows it is possible to produce a tissue-engineered airway with mechanical properties that permit normal breathing and which is free from the risks of rejection seen with conventional transplanted organs. The patient has not developed antibodies to her graft, despite not taking any immunosuppressive drugs. Lung function tests performed two months after the operation were all at the better end of the normal range for a young woman.

The loss of a normal airway is devastating, but previous attempts to replace large airways have met serious problems. The 30-year-old mother of two, suffering from collapsed airways following a severe case of TB, was hospitalized in March 2008 with acute shortness of breath rendering her unable to carry out simple domestic duties or care for her children. The only conventional option remaining was a major operation to remove her left lung which carries a risk of complications and a high mortality rate.  Based on successful laboratory work previously performed by the team, and given the urgency of the situation, it was proposed that the lower trachea and the tube to the patient’s left lung (bronchus) should be replaced with a bio-engineered airway based on the scaffold of a human trachea.

A seven-centimeter tracheal segment was donated by a 51-year-old transplant donor who had who had died of cerebral hemorrhage. Spain has a policy of assumed consent for organ donation. Using a new technique developed in Padua University, the trachea was decellularised over a six-week period so that no donor cells remained.  Stem cells were obtained from the recipient’s own bone marrow, grown into a large population in Professor Martin Birchall’s lab at the University of Bristol, and matured into cartilage cells (chondrocytes) using an adapted method originally devised for treating osteoarthritis

The donor trachea was then seeded with chondrocytes on the outside, using a novel bio-reactor which incubates cells, allowing them to migrate into the tissue under conditions ideal for each individual cell type. In order to replicate the lining of the trachea, epithelial cells were seeded onto the inside of the trachea using the same bio-reactor.  Four days after seeding, the graft was used to replace the patient’s left main bronchus. The operation was performed in June 2008 at the Hospital Clinic, Barcelona, by Professor Paolo Macchiarini of the University of Barcelona.

Professor Macchiarini, lead author on the paper, said: “We are terribly excited by these results. Just four days after transplantation the graft was almost indistinguishable from adjacent normal bronchi. After one month, a biopsy elicited local bleeding, indicating that the blood vessels had already grown back successfully”.

Martin Birchall, Professor of Surgery at the University of Bristol, added: “Surgeons can now start to see and understand the very real potential for adult stem cells and tissue engineering to radically improve their ability to treat patients with serious diseases. We believe this success has proved that we are on the verge of a new age in surgical care”.

Anthony Hollander, Professor of Rheumatology and Tissue Engineering at the University of Bristol, concurred: “This successful treatment manifestly demonstrates the potential of adult stem cells to save lives”.

The patient, Claudia Castillo, a young woman from Colombia but now living in Spain, had no complications from the operation and was discharged from hospital on the tenth post-operative day. She has remained well since and has a normal quality of life. She is able to care for her children, walk up two flights of stairs and occasionally go out dancing in the evenings.

http://www.science20.com

Follow

Get every new post delivered to your Inbox.

Join 1,233 other followers

%d bloggers like this: